Home > Insider Trading > Filing (0001209191-22-050957)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1501756	Adverum Biotechnologies Inc.	ADVM	Biological Products, (No Disgnostic Substances) (2836)	205258327

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1908942	Richard Beckman	C/O Adverum Biotechnologies, Inc. 100 Cardinal Way Redwood City CA 94063	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-09-19	4,272	$1.07	39,061	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain performance stock units.
The reporting person's sale of Adverum common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the reporting person's purchase of the same number of shares of Adverum common stock at a price of $0.8228 per share on May 17, 2022. The reporting person has paid to Adverum $1,055.01, representing the full amount of the profit realized in connection with the short-swing transaction.
Price reported is a weighted-average sale price. The shares were sold at prices ranging from $1.069589 to $1.0721. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.